Multimodality therapy improves survival in elderly patients with locally advanced non-small cell lung cancer-A retrospective analysis

Journal of Geriatric Oncology

Volumn 3, Issue 2, 2012, Pages 104-110

  Paripati, Harshita R ^a   Karlin, Nina J ^a   Schild, Steven E ^a   Vora, Sujay A ^a   Dueck, Amylou C ^a   Ross, Helen J ^a  

^a Mayo Clinic Arizona   (United States)

Author keywords

Elderly; Non small cell lung cancer; Performance status

Indexed keywords

ANTINEOPLASTIC AGENT;

AGED; AGING; ARTICLE; BLOOD TOXICITY; CANCER STAGING; CANCER SURVIVAL; CHEMORADIOTHERAPY; COHORT ANALYSIS; CONTROLLED STUDY; ERYTHEMA; ESOPHAGITIS; FATIGUE; FEMALE; HUMAN; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; MULTIMODALITY CANCER THERAPY; PNEUMONIA; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; SIDE EFFECT; SKIN MANIFESTATION; SURVIVAL TIME; WEIGHT REDUCTION;

EID: 84858792116     PISSN: 18794068     EISSN: 18794076     Source Type: Journal    
DOI: 10.1016/j.jgo.2011.12.002     Document Type: Article

References (15)

1. Howlader N, Noone AM, Krapcho M, et al. National Cancer Institute, Surveillance, Epidemiology, and End Results (SEER) Program: SEER incidence crude rates. SEER Cancer Statistics Review, 1975-2008, National Cancer Institute. Bethesda, MD, http://seer.cancer.gov/csr/1975_2008/, based on November 2010 SEER data submission, posted to the SEER web site, 2011.
2. Ries LAG, Melbert D, Krapcho M, et al., SEER Cancer Statistics Review, 1975-2005, National Cancer Institute. Bethesda, MD, based on November 2007 SEER data submission, posted to the SEER web site, 2008. http://seer.cancer.gov/csr/1975_2005/.
3. Dillman R.O., Seagren S.L., Propert K.J., et al. A randomized trial of induction chemotherapy plus high-dose radiation versus radiation alone in stage III non-small-cell lung cancer. N Engl J Med 1999, 323(14):940-945.
4. Dillman R.O., Herndon J., Seagren S.L., Eaton W.L., Green M.R. Improved survival in stage III non-small-cell lung cancer: seven-year follow-up of cancer and leukemia group B (CALGB) 8433 trial. J Natl Cancer Inst 1996, 88(17):1210-1215.
5. Furuse K., Fukuoka M., Kawahara M., et al. Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine and cisplatin in patients with unresectable stage III non-small cell lung cancer. J Clin Oncol 1999, 17:2692-2699.
6. National Cancer Database. Facility Oncology Registry Data Standards (FORDS) http://www.facs.org/cancer/coc/fordsmanual.html.
7. Sause W., Kolesar P., Taylor S., et al. Final results of Phase III trial in regionally advanced unresectable non-small cell lung cancer: Radiation Therapy Oncology Group, Eastern Cooperative Oncology Group, and Southwest Oncology Group. Chest Feb 2000, 117:358-364.
8. Curran W.J., Scott C.B., Langer C.J., Komaki R., Lee J.S., Hauser S., et al. Long-term benefit is observed in a phase III comparison of sequential vs concurrent chemo-radiation for patients with unresected state III nsclc: RTOG 9410. Proc Am Soc Clin Oncol 2003, 22:621. (Abstr. #2499).
9. Langer C.J., Hsu C., Curran W.J., et al. Elderly patients with locally advanced non-small cell lung cancer benefit from combined modality therapy: secondary analysis of radiation therapy oncology group (RTOG) 94-10. Proc Am Soc Clin Oncol 2002, 21:299a. (abst 1193).
10. Auperin A., LePechoux C., Rolland E., et al. Meta-analysis of concomitant versus sequential radiochemotherapy in locally advanced non-small cell lung cancer. J Clin Oncol 2010, 28(13):2181-2190.
11. Schild S.E., Stella P.J., Geyer S.M., et al. The outcome of combined-modality therapy for stage III non-small-cell lung cancer in the elderly. J Clin Oncol 2003, 21:3201-3206.
12. Treatment of non-small cell lung cancer, Stage IIIB*ACCP evidence-based clinical practice guidelines (2nd Edition) James R. Jett, MD, FCCP; Steven E. Schild, MD; Robert L. Keith, MD, FCCP and Kenneth A. Kesler, MD, FCCP. Chest 2007 Sep;132(3 Suppl):266S-276S.
13. Rocha Lima C.M., Herndon J.E., Kosty M., et al. Therapy choices among older patients with lung carcinoma: an evaluation of two trials of the Cancer and Leukemia Group B. Cancer 2002, 94(1):181-187.
14. Jatoi A., Schild S.E., Foster N., et al. A Phase II study of cetuximab and radiation in elderly and/or poor performance status patients with locally-advanced non-small cell lung cancer (N0422). Ann Oncol 2010, (First published online: June 21, 2010). 10.1093/annonc/mdq075.
15. Extermann M., et al. Use of comprehensive geriatric assessment in older cancer patients: recommendations from the task force on CGA of the International Society of Geriatric Oncology (SIOG). Crit Rev Oncol Hematol 2005 Sep, 55(3):241-252.